A Medical Device Daily
SRA International (Fairfax, Virginia) a provider of technology and strategic consulting services and solutions to federal government organizations, has been awarded a competitive task order to provide a broad range of technical services to the National Institutes of Health (NIH; Bethesda, Maryland) Office of Research Services (ORS). The task order, awarded under the Chief Information Officer Solutions and Partners 2 Innovations (CIO-SP2i) contract, has an estimated value of $25.5 million over four years if all options are exercised.
SRA has provided business systems and technology services to ORS since 2001. Under this new contract, the SRA team will support the ORS enterprise architecture for business users and systems while coordinating with NIH-wide technology and business initiatives; analyze programmatic requirements; design and enhance new and existing systems; support Internet and intranet applications; and help ORS develop a technology insertion strategy.
SRA is a provider of technology and strategic consulting services and solutions — including systems design, development, and integration; and outsourcing and managed services — to clients in national security, civil government, and health care and public health markets.
OSI Systems (Hawthorne, California) a provider of specialized electronic products for critical applications in the security and healthcare industries, reported that its Security division, Rapiscan Systems (Sunnyvale California) has been awarded a $9.3 million contract from the Transportation Security Administration (TSA) for its 620DV Advanced Technology X-ray systems.
The contract, representing half of the total systems currently ordered by TSA, follows successful piloting of Advanced Technology (AT) Passenger Carry-On Bag Screening Systems at select airport locations. Under the terms of the agreement, the company expects to begin delivering the systems to the TSA in the second quarter of the company’s fiscal year.
Rapiscan Systems President, Ajay Mehra, said, “We are pleased to be working closely with the TSA in this critical program. This program represents the deployment of one of the most advanced technologies available today for passenger checkpoint screening. The Rapiscan 620DV system is designed specifically to detect aviation based threats while improving checkpoint operations.”
Rapiscan is a supplier of security inspection solutions utilizing X-ray and gamma-ray imaging, and advanced threat identification techniques such as neutron and diffraction analysis.
• MedAssets Supply Chain Systems, the group purchasing division of MedAssets (Alpharetta, Georgia) and Inviro Medical Devices (Lawrenceville, Georgia) have extended their contract, providing MedAssets customers access to Inviro’s portfolio of safety hypodermic needle and syringe products.
The extension adds five months and is active through July 31, 2008.
In grants news: 20/20GeneSystems, (Rockville, Maryland) reported that the National Institute of Standards and Technology (NIST) Advanced Technology Program (ATP) has awarded $1.9 million to 20/20 GeneSystems for the development of a technique known as Layered Expression Scanning-Diagnostic (LES-Dx) for tumor profiling to better predict whether cancer patients will respond to certain “personalized” chemotherapy drugs.
Currently, once cancer is suspected, a clinical specimen or biopsy sample is taken for pathology assessment. With existing tumor analysis unable to simultaneously analyze the visible characteristics of the tumor together with the underlying biomarkers (proteins) or gene expression patterns, 20/20 plans to develop a test approach to address this unmet need. This test will provide additional information to assist oncologists in making specific treatment selections and decisions for their patients.